As the vaccine distribution continues across the world, Interpol has issued a global alert to all of its 194-member countries, warning governments, businesses and citizens to prepare for organized crime networks targeting vaccines both physically and online. Pharmaceutical supply chains will be the next hot target as criminals attempt to intercept shipments and steal highly demanded Covid-related products, especially vaccine and testing kits. It is critical for pharmaceutical supply chains to secure storage, transportation, and delivery of their cargo shipments to not only safeguard against theft, but to avoid contamination of the cargoes.
In this webinar and panel discussion, we explore the impact and security challenges of the vaccine on supply chains, key strategies to mitigate risk losses and the upcoming supply chain concerns. Experts from the Transported Asset Protection Association (TAPA), Pharmaceutical Security Institute (PSI) and Eli Lilly will share their experience and knowledge on how to secure the pharmaceutical cargo against new risks arising from the vaccine release and distribution.
- 0:01:13 – With the global demand for vaccines exceeding the existing supply, what are the major risks to the supply chain and further to consumers?
- 0:28:27 – What solutions are essential to mitigate the risks that confront pharma firms and other stakeholders?
- 0:36:22 – In a high-risk environment, data sharing is an important element. What is data-sharing? With whom and what?
- 0:41:08 – What other supply chain issues or concerns do you expect in the upcoming months?
Download the Webinar Presentation Slides here.
About the Speakers
Ramesh Raj Kishore
Regional Director – Asia Pacific of Pharmaceutical Security Institute (PSI)
Ramesh had a distinguished career while serving in the public sector for almost three decades. He has held various positions in the Intelligence & Investigation departments within the Singapore Police Force and was the Head of the Enforcement Operations Unit whilst with the Health Sciences Authority (HSA). During this time, Ramesh was also the co-trainer with Interpol carrying training programs for Law Enforcement Agencies in the region. His accomplishments included several successfully prosecuted landmark cases involving rouge medical practitioners and counterfeit medical devices.
Regional Security Manager – Asia at Eli Lilly and Company
Raymond Velez is currently the Global Security Regional Manager of Asia Pacific in Eli Lilly, managing security and an‐counterfeiting operations in the Asia Pacific region, based in Thailand. Raymond used to work at US Federal Bureau of Investigation (FBI). During his career he was assigned to various offices in the United States as well as Thailand, India and Pakistan. He has broad experience in complex investigations to include fraud, drug trafficking and terrorism. He has also conducted training for government agencies including drug regulatory agencies, customs and the police throughout Asia and the United States.
Board Member at TAPA Asia Pacific
Selvaraj is the Head of Infrastructure, Safety, and Environmental Sustainability & Engineering (ISEE) and Security at Boehringer Ingelheim Singapore Pte. Ltd. in Asia Pacific. With a combination of his expertise in both Safety and Security, he is able to advise and lead organizations towards recovery and maintain operational capabilities at the same time in any situations. Selvaraj is also sits on the Board of Directors and the Working Committee Lead for TAPA Information Incident Service (IIS)
Malek Ali (Moderator)
IIS Working Committee at TAPA Asia Pacific
Malik currently is the Regional Marine Loss Control Manager at AIG APAC Holdings Pte Ltd. has over 20 years of experience with 16 years in the marine surveying industry, conducting wide range and variety of surveys, cargo inspections and investigation work for Cargo Underwriters, Liability Insurers and P and I Clubs, and 5 years of sea service on board general cargo, bulk carrier and container vessels trading worldwide. He has also carried out survey and supervision of vessels involved in GA situation or forced discharged, sale and disposal of distressed and rejected cargoes. Malik also sits on the working committee in TAPA Incident Information Service (IIS).
About Pharmaceutical Security Institute (PSI)
In 2002, the Security Directors from fourteen major pharmaceutical companies established the Institute in Washington, D.C. Working with its members, PSI developed improved systems to identify the extent of the problem and to assist in coordinating international inquiries.
Today, PSI membership includes thirty-seven pharmaceutical manufacturers from many nations. The Institute established representational offices with staff in Miami, Florida; Singapore; and Stockholm, Sweden.
About Eli Lilly & Company
Lilly was founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that met real needs in an era of unreliable elixirs peddled by questionable characters. His charge to the generations of employees who have followed was this: “Take what you find here and make it better and better.”
More than 140 years later, we remain committed to his vision through every aspect of our business and the people we serve starting with those who take our medicines, and extending to health care professionals, employees and the communities in which we live.